Centanafadine for depression alone or with an antidepressant
About this title
Read the official source — NCT05536414This study evaluated the safety and effectiveness of Centanafadine for people with depression.
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of Centanafadine for people with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Yuma and 61 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 337
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05536414
- Official title
Show the full official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Extended-release Capsules as Monotherapy or as Adjunct to SSRI in Adult Subjects With Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Yuma · Bryant · Glendale
53 more locations
- Lafayette
- Lancaster
- Lemon Grove
- Orange
- Rancho Cucamonga
- Redlands
- San Jose
- Santa Ana
- Sherman Oaks
- Temecula
- Coral Springs
- Fort Myers
- Jacksonville
- Miami Springs
- North Miami
- Orlando
- Tampa
- Atlanta
- Decatur
- Marietta
- Peachtree Corners
- Boise
- Chicago
- Elgin
- Oak Brook
- Shreveport
- Baltimore
- Flowood
- O'Fallon
- Toms River
- Brooklyn
- New York
- Rochester
- Staten Island
- Cincinnati
- Garfield Heights
- North Canton
- Oklahoma City
- Portland
- West Chester
- Myrtle Beach
- Memphis
- Dallas
- DeSoto
- Houston
- Irving
- Plano
- Wichita Falls
- Clinton
- Draper
- Bennington
- Charlottesville
- Everett
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of Centanafadine for people with depression.
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Centanafadine, Escitalopram and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
